MacroGenics: Working On That Road To Recovery

MacroGenics, Inc. (NASDAQ: MGNX ) has been a story I've covered for quite a while now, with my most recent write-up focusing on the various factors stacking against the investment thesis. The story hasI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in ...